Investing.com - Cue Health (NASDAQ: HLTH) reported third quarter EPS of $-0.3100, $0.13 better than the analyst estimate of $-0.4400. Revenue for the quarter came in at $17.5M versus the consensus estimate of $11.81M.
Guidance
Cue Health sees Q4 2023 revenue of $16.0000M-$18.0000M versus the analyst consensus of $27.4500M.
Cue Health's stock price closed at $0.3200. It is down -18.6600% in the last 3 months and down -91.5300% in the last 12 months.
Cue Health saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Cue Health's stock price’s past reactions to earnings here.
According to InvestingPro, Cue Health's Financial Health score is "weak performance".
Check out Cue Health's recent earnings performance, and Cue Health's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar